RxDoctor Payments Data

Harry Pantelides, MD

Otolaryngology · Astoria, NYNPI 1063643641

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $17,000 of the $22,197 with a category attached, or 76.6%. 8 manufacturers reported payments, led by Acclarent, Inc at 49.4% of the total. Reporting peaked in 2022 at $14,346 and has fallen 98.2% since, to $252 in 2025. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,197in general payments, 2019–2025

Across 92 payments — averaging $241.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$11K
  • Medical Device Business Services, Inc.$10K
  • Integra Lifesciences Corporation$477
  • Optinose US, Inc.$278
  • Intersect ENT, Inc.$129
  • Medtronic$128
  • plus $70 from 2 others

What the payments were for

  • Consulting fees$17,00077%
  • Travel & lodging$2,16010%
  • Food & beverage$3,03814%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,197 in reported general payments places this provider in the 95th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$103,741
Medicare patients
242
Services billed
800

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth41$3,644
Tobramycin-DexamethasoneTobramycin/Dexamethasone48$2,468
Fluticasone Propionate183$1,605
Ofloxacin18$1,372
Famotidine182$1,043
Ipratropium Bromide50$953
Clotrimazole18$552
Triamcinolone Acetonide99$403
Cefdinir27$365
Azelastine Hcl20$362
Omeprazole40$277
Mupirocin32$187
Methylprednisolone13$120
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$77
Amoxicillin12$36

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Astoria

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →